The book discusses the issues in access to health care and role of intellectual property rights in access to drugs as well as scope for using traditional medicine for public health purposes. Experts from different countries including India, China, the UK and Germany here deal with the Health Impact Fund, a mechanism that is proposed to incentivise research and development and improve access to drugs across countries. They delve into the HIF’s objectives and implementation and how cooperation between India and China is possible in the health sector. They include an overview on the status of traditional medicine in both these countries and challenges in this sector with reference to regulation, IPRs and industrial policy.
ABOUT THE AUTHOR Sachin Chaturvedi
Dr. Sachin Chaturvedi, Fellow, RIS and Managing Editor of the Asian Biotechnology and Development Review (ABDR) has been working on Intellectual Property Regime; trade and environment related issues in WTO. His areas of specialization include economics of biotechnology and biodiversity. Dr. Chaturvedi has authored two books and has published several research articles in various prestigious journals. He has also worked at University of Amsterdam under a project supported by the Dutch Government on International Development Cooperation and Biotechnology for Developing Countries. Dr. Chaturvedi has also been a member of the IGSAC Committee of Experts to evolve a framework of Co-operation for conservation of biodiversity in the SAARC region; and Editorial Board of Biotechnology Development Monitor, Netherlands.
There are no reviews yet.